2nd Annual Gene Therapy for Neurological Disorders


Tuesday, December 8, 2020 - Thursday, December 10, 2020


Virtual attendees at the 2nd Gene Therapy for Neurological Disorders USA


Gene therapy holds great promise for neurological diseases. Researchers are delivering these molecular treatments to the brain with precision and efficiency, in both small and larger animal species. This translation has armed scientists with potentially lifesaving treatments for humans. Discover the assays, tools and approaches that can propel your research further into the new era of CNS discovery through our dedicated neuroscience portal.

Returning this year as a digital meeting with an agenda designed with the field’s thought-leaders, the 2nd Annual Gene Therapy for Neurological Disorders is the industry’s only meeting dedicated to solving your translational drug development challenges, enabling you to accelerate the development of your neurological gene therapy candidate.

Don't get left behind. Attend this meeting to transform gene therapy delivery to the CNS, optimize translational modelling approaches and discover targeted, efficacious and safe vectors to revolutionize the treatment of neurological disorder.

Don’t miss Dr. Enrique Rodriguez’s presentation on translational imaging techniques for rodents and large species, MRI-guided gene delivery, and microdialysis for PK/PD studies during the meeting’s CNS Gene Delivery and Therapy session.

About Enrique
Enrique Rodriguez headshotEnrique joined Charles River in 2017 through the acquisition of Encepharm/Brains-Online. He has worked in academia for 10 years with postdoctoral positions at the University of Freiburg and the German Primate Center. Enrique graduated in biology at the University of Bielefeld and obtained his PhD in neuroscience from the University of Göttingen. Key areas of expertise: drug discovery, CNS disease models, imaging, and gene therapy. He has published 9 peer-reviewed research articles.